These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25015689)

  • 1. Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.
    Capoulade R; Côté N; Mathieu P; Chan KL; Clavel MA; Dumesnil JG; Teo KK; Tam JW; Fournier D; Després JP; Pibarot P;
    Can J Cardiol; 2014 Sep; 30(9):1088-95. PubMed ID: 25015689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):165-74. PubMed ID: 23489530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial.
    Chan KL; Teo K; Tam J; Dumesnil JG;
    Am Heart J; 2007 Jun; 153(6):925-31. PubMed ID: 17540192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.
    Chan KL; Teo K; Dumesnil JG; Ni A; Tam J;
    Circulation; 2010 Jan; 121(2):306-14. PubMed ID: 20048204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    J Am Coll Cardiol; 2012 Jul; 60(3):216-23. PubMed ID: 22789885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).
    van der Linde D; Yap SC; van Dijk AP; Budts W; Pieper PG; van der Burgh PH; Mulder BJ; Witsenburg M; Cuypers JA; Lindemans J; Takkenberg JJ; Roos-Hesselink JW
    Am J Cardiol; 2011 Jul; 108(2):265-71. PubMed ID: 21565321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
    Moura LM; Ramos SF; Zamorano JL; Barros IM; Azevedo LF; Rocha-Gonçalves F; Rajamannan NM
    J Am Coll Cardiol; 2007 Feb; 49(5):554-61. PubMed ID: 17276178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.
    Jassal DS; Tam JW; Dumesnil JG; Giannoccaro PJ; Jue J; Pandey AS; Joyner CD; Teo KK; Chan KL
    J Am Soc Echocardiogr; 2008 Sep; 21(9):1023-7. PubMed ID: 18406575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.
    Capoulade R; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    Atherosclerosis; 2017 May; 260():1-7. PubMed ID: 28319871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
    Jassal DS; Bhagirath KM; Karlstedt E; Zeglinski M; Dumesnil JG; Teo KK; Tam JW; Chan KL
    Cardiovasc Ultrasound; 2011 Feb; 9(1):5. PubMed ID: 21299902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
    Jassal DS; Tam JW; Bhagirath KM; Gaboury I; Sochowski RA; Dumesnil JG; Giannoccaro PJ; Jue J; Pandey AS; Joyner CD; Teo KK; Chan KL
    Eur Heart J; 2008 Jun; 29(12):1542-7. PubMed ID: 18443031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.
    Capoulade R; Mahmut A; Tastet L; Arsenault M; Bédard É; Dumesnil JG; Després JP; Larose É; Arsenault BJ; Bossé Y; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):26-33. PubMed ID: 25499129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
    Jassal DS; Bhagirath KM; Tam JW; Sochowski RA; Dumesnil JG; Giannoccaro PJ; Jue J; Pandey AS; Joyner CD; Teo KK; Chan KL
    Echocardiography; 2010 Feb; 27(2):174-9. PubMed ID: 19725842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive lipid-lowering therapy for patients with aortic stenosis.
    Pedersen TR
    Am J Cardiol; 2008 Dec; 102(11):1571-6. PubMed ID: 19026317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin).
    Pagé A; Dumesnil JG; Clavel MA; Chan KL; Teo KK; Tam JW; Mathieu P; Després JP; Pibarot P;
    J Am Coll Cardiol; 2010 Apr; 55(17):1867-74. PubMed ID: 20413039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.
    Tastet L; Capoulade R; Shen M; Clavel MA; Côté N; Mathieu P; Arsenault M; Bédard É; Tremblay A; Samson M; Bossé Y; Dumesnil JG; Arsenault BJ; Beaudoin J; Bernier M; Després JP; Pibarot P
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis.
    Ueland T; Gullestad L; Dahl CP; Aukrust P; Aakhus S; Solberg OG; Vermeer C; Schurgers LJ
    J Intern Med; 2010 Nov; 268(5):483-92. PubMed ID: 20804515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
    Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.